Visualization of coronary plaque in type 2 diabetes mellitus patients using a new 40MHz intravascular ultrasound imaging system  by Araki, Tadashi et al.
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Summary
Background:  Previous  epidemiological  studies  demonstrated  plaque  vulnerability  to  be  high
in diabetic  patients.  iMap-intravascular  ultrasound  (IVUS)  is  a  recently  developed  radiofre-
quency 40  MHz  IVUS  imaging  system  for  tissue  characterization.  This  study  aimed  to  characterize
coronary  plaque  in  target  lesions  of  diabetic  patients  using  iMap-IVUS.
Methods:  We  studied  175  treated  vessels  in  146  patients  with  stable  angina  pectoris  and  analyzed
plaque components  of  culprit  lesions  by  iMAP-IVUS.  Patients  were  divided  into  2  groups:  non-
diabetic (non-DM:  112  vessels,  93  patients)  and  diabetic  (DM:  63  vessels,  53  patients).
Results:  In  gray-scale  IVUS  2D  analysis,  there  were  no  differences  in  IVUS  parameters.
In 3D  analysis,  the  DM  group  tended  to  have  a  larger  plaque  volume  (p  =  0.07)  and
plaque burden  (p  =  0.10).  At  minimum  lumen  sites,  the  absolute  lipidic  and  necrotic  areas
(0.84 ±  0.44  mm2 vs.  0.58  ±  0.41  mm2,  p  <  0.001,  and  2.42  ±  1.65  mm2 vs.  1.46  ±  1.76  mm2,
p <  0.001,  respectively)  and  percent  lipidic  and  necrotic  areas  were  signiﬁcantly  greater
in the  DM  than  in  the  non-DM  group  (8.39  ±  3.38%  vs.  5.25  ±  2.30%,  p  <  0.0001,  and
23.65 ±  11.54%  vs.  12.99  ±  10.71%,  p  <  0.0001,  respectively).  In  addition,  the  absolute  lipidic
and necrotic  volumes  (11.75  ±  10.59  mm3 vs.  8.18  ±  6.24  mm3,  p  <  0.01,  and  29.99  ±  28.90  mm3
vs.  19.44  ±  19.35  mm3,  p  <  0.01,  respectively)  and  percent  lipidic  and  necrotic  volumes  were  sig-
niﬁcantly greater  in  the  DM  than  in  the  non-DM  group  (6.27  ±  1.92%  vs.  5.13  ±  1.82%,  p  <  0.0001,
and 16.54  ±  7.56%  vs.  12.08  ±  6.05%,  p  <  0.0001,  respectively).
on  of  coronary  plaque  by  iMAP-IVUS  in  diabetic  patients  showedConclusion:  Characterizati
increased  lipidic  amount  and  necrotic  plaque  volume  relative  to  subjects  without  DM.
© 2011  Japanese  College  of  Cardiology.  Published  by  Elsevier  Ltd.  All  rights  reserved.
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Introduction
Type  2  diabetes  mellitus  (DM)  is  strongly  associated  with  the
development  of  coronary  heart  disease  [1].  Patients  with  DM
also  have  higher  mortality  and  risk  for  acute  coronary  syn-
drome  (ACS)  than  non-DM  patients  [2].  Pathological  studies
showed  the  main  cause  of  ACS  to  be  rupture  of  a  thin-capped
ﬁbroatheroma  with  a  large  necrotic  core  [3].  Previous  stud-
ies  of  ACS  patients  using  gray-scale  intravascular  ultrasound
(IVUS)  demonstrated  that  plaque  rupture,  thrombosis,  and
vessel  remodeling  are  associated  with  plaque  vulnerabil-
ity.  However,  this  technique  is  less  accurate  in  assessing
soft  tissue  components,  and  has  been  regarded  as  a  lim-
itation  of  gray-scale  IVUS  [4].  Spectral  analysis  of  IVUS
which  allows  detailed  assessment  of  components  has  been
suggested  to  be  more  useful  for  evaluating  plaque  charac-
teristics  than  gray-scale  IVUS  [5].  Recently,  several  studies
employing  virtual  histology-IVUS  (VH-IVUS)  (Volcano  Ther-
apeutics,  Inc.,  Rancho  Cordova,  CA,  USA)  have  shown  an
increased  amount  of  necrotic  core  in  the  coronary  plaques
of  type  2  DM  patients  [6].  While  a  VH-IVUS  system  has  only
20  MHz  in  gray-scale  resolution,  iMap-IVUS  (iMap;  Boston
Scientiﬁc  Corp,  Fremont,  CA,  USA)  is  a  recently  devel-
oped  IVUS  imaging  system  for  tissue  characterization  with
40  MHz  radiofrequency.  iMap  software  converts  the  signal
pattern  into  a  frequency  spectrum,  and  then  compares  it
with  spectra  obtained  from  various  tissues  at  autopsy  (‘‘data
library’’)  to  ﬁnd  the  closest  match.  Since  different  tissue
types  (ﬁbrotic,  lipidic,  necrotic,  and  calciﬁed)  have  distinc-
tive  spectra,  iMap  technology  can  identify  tissues  from  the
frequency  spectrum  that  most  closely  resembles  the  one
obtained  by  examination  [7].  Furthermore,  this  system  pro-
vides  volumetric  analysis.  We  assessed  the  coronary  plaque
characterization  in  culprit  lesions  in  atherosclerotic  vessels
of  diabetic  patients  with  stable  angina  pectoris  (SAP)  using
iMAP-IVUS.
Materials and methods
Study  population
In  this  single-center  study,  a  total  of  146  patients  were
selected  from  159  consecutive  SAP  patients.  They  under-
went  percutaneous  coronary  intervention  (PCI)  and  also
iMap-IVUS  examination  between  July  2009  and  September
2010.  SAP  was  deﬁned  as  class  I  or  II  angina  unchanged
for  more  than  2  months  or  a  positive  stress  test.  The  tar-
get  lesion  was  de-novo  (>75%  angiographic  stenosis  by  visual
estimation)  and  identiﬁed  by  a  combination  of  left  ventric-
ular  wall  motion  abnormalities,  electrocardiogram  ﬁndings,
angiographic  lesion  morphology,  and  scintigraphic  defects.
In  total,  13  patients  were  excluded  because  of  9  in-stent
restenosis,  2  visible  thrombus  with  angiography,  and  2  inad-
equate  IVUS  images.  The  study  population  consisted  of  146
patients  (175  vessels).  All  patients  underwent  stent  implan-
tation.  Type  2  DM  was  deﬁned  as  receiving  oral  hypoglycemic
agents,  insulin  to  lower  blood  glucose  levels,  known  fast-
ing  blood  glucose  values  of  ≥126  mg/dl,  and/or  postprandial
2-h  blood  glucose  values  ≥200  mg/dl.  Hyperlipidemia  was
deﬁned  as  a  total  cholesterol  (TC)  level  ≥220  mg/dl,  low-
density  lipoprotein  (LDL)  cholesterol  ≥140  mg/dl,  fasting
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riglycerides  (TG)  ≥150  mg/dl,  or  medication  use.  Hyper-
ension  was  deﬁned  as  systolic  blood  pressure  ≥140  mmHg,
iastolic  blood  pressure  ≥90  mmHg,  or  use  of  an  antihyper-
ensive  drug.  Estimated  glomerular  ﬁltration  rates  (eGFR)
ere  calculated  by  the  modiﬁcation  of  diet  in  renal  disease
MDRD):  eGFR  (ml/min/1.73  m2)  =  194  ×  Cr−1.094 ×  Age−0.287
Corrected  for  females  by  multiplication  with  a factor  of
.739)  [8].  LDL  concentration  is  estimated  indirectly  from
he  measured  levels  of  TG,  high-density  lipoprotein  choles-
erol  (HDL),  and  TC  using  the  Friedewald  equation:  LDL
mg/dl)  =  TC  −HDL  — (TG/5)  [9].  The  value  for  HbA1c  (%)
as  estimated  as  a  National  Glycohaemoglobin  Standard-
zation  Program  (NGSP)  equivalent  value  (%),  calculated  by
he  formula  HbA1c  (%)  =  HbA1c  (Japan  Diabetes  Society;  JDS)
%)  +  0.4%.  This  calculation  takes  into  consideration  the  rela-
ionship  between  HbA1c  (JDS)  (%),  measured  by  the  previous
apanese  standard  substance  and  measurement  methods,
nd  HbA1c  (NGSP)  [10]. Approval  to  conduct  the  study
as  obtained  from  the  ethics  committee  at  our  institute,
nd  written  informed  consent  was  provided  by  all  partici-
ants.
CI  procedure
he  patients  were  pre-medicated  with  aspirin  (100  mg/day)
lus  clopidogrel  (75  mg/day)  for  at  least  a  week  before
he  procedure.  They  also  received  intravenous  unfraction-
ted  heparin  just  before  PCI  to  achieve  an  activated  partial
hromboplastin  time  >250  s.  None  of  the  patients  were  given
lycoprotein  IIb/IIIa  inhibitors  because  these  drugs  have  not
een  approved  in  Japan.
VUS  imaging  and  analysis
VUS  was  performed  before  stenting  and  after  intra-coronary
dministration  of  125—250  g  of  nitroglycerin.  Data  were
cquired  with  a  40  MHz  IVUS  catheter  (Atlantis  SR  Pro,
oston  Scientiﬁc).  The  catheter  was  advanced  beyond  the
arget  lesion,  and  imaging  was  performed  during  auto-
atic  pullback  at  a  speed  of  0.5  mm/s.  The  IVUS  data
ere  stored  on  a  hard  disk  for  off-line  analysis,  which
as  performed  independently  by  2  experienced  analysts
T.A.  and  M.U.)  who  were  unaware  of  the  angiographic
ndings  or  the  baseline  clinical  and  lesion  characteristics.
he  ﬁrst  observer  repeated  a blind  analysis  of  all  of  the
ata  at  2  separate  time  points  (with  an  interval  of  at
east  1  month  between  the  2  analyses).  Quantitative  anal-
sis  of  gray-scale  IVUS  images  was  performed  according  to
he  criteria  of  the  American  College  of  Cardiology  Clini-
al  Expert  Consensus  Document  on  IVUS  [11]. Lesions  were
ualitatively  analyzed  with  iMap  software  (QIvus  2.0,  Medis
edical  Imaging  Systems  bv,  Leiden,  The  Netherlands).  The
xternal  elastic  membrane  (EEM)  and  lumen  cross-sectional
rea  (CSA)  were  measured.  Plaque  CSA  was  calculated
s  EEM  minus  lumen  CSA,  and  plaque  burden  was  cal-
ulated  as  plaque  plus  media  divided  by  EEM  CSA.  The
inimum  lumen  site  at  the  culprit  lesion  was  identiﬁed
rom  axial  and  longitudinal  plaques.  If  there  were  several
lices  with  equal  lumen  sizes,  the  one  with  the  largest  EEM
nd  plaque  CSA  was  selected.  Lesion  length  was  deﬁned
s  the  segment  between  distal  to  proximal  reference  sites
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hat  appeared  normal  within  5  mm  proximal  and  distal  to
he  lesion.  Proximal  and  distal  references  were  the  single
lices  with  the  largest  lumen  and  smallest  plaque  burden
ithin  5  mm  proximally  and  distally,  but  before  any  large
ide  branch.
Map-IVUS  tissue  characterization
he  iMap-IVUS  analysis  classiﬁed  plaque  into  4  tissue
omponents  and  produced  color  images  (green  for  ﬁbrotic
laque,  yellow  for  lipidic  plaque,  red  for  necrotic  plaque,
nd  blue  for  calciﬁed  plaque)  (Fig.  1).  The  absolute  plaque
rea  (mm2),  plaque  volume  (mm3),  and  percentage  of  each
issue  component  were  determined.  The  percent  plaque
olume  was  deﬁned  as  the  ratio  of  plaque  volume  to  EEM
olume,  and  each  plaque  component  was  represented  as
 ratio  of  the  total  plaque  volume  (%ﬁbrotic,  %lipidic,
necrotic,  and  %calciﬁed).  The  percent  plaque  area  and
ach  component  were  also  deﬁned.  Plaque  that  was
nsuitable  for  analysis  was  deﬁned  as  acoustic  shadowing
rea  and  volume  behind  calciﬁcation  or  wire  artifact  and
emoved  automatically  because  we  could  not  analyze  this
laque  accurately.  The  plaque  area  found  to  be  unsuit-
ble  for  analysis  was  1.22  ±  0.99  mm2 (11.84  ±  8.22%)
n  the  DM  and  1.23  ±  1.15  mm2 (11.65  ±  9.21%)  in
he  non-DM  group.  The  volume  unsuitable  for  analy-
is  was  20.66  ±  18.92  mm3 (11.48  ±  5.59%)  in  the  DM
nd  15.64  ±  14.01  mm3 (9.88  ±  4.92%)  in  the  non-DM
roup.
tatistical  analysis
ontinuous  variables  are  expressed  as  the  mean  ±  standard
eviation,  while  discrete  variables  are  presented  as  num-
ers  and  percentages.  Differences  in  mean  values  between
roups  were  assessed  by  the  unpaired  Student’s  t-test.  Cat-
gorical  data  were  compared  using  chi-square  statistics  or
isher’s  exact  test.  Linear  regression  analysis  was  used  to
valuate  the  correlation  between  intra-  and  inter-observer
ariability  by  using  Pearson  correlation  coefﬁcients.  A  two-
ided  p-value  <0.05  was  required  for  statistical  signiﬁcance.
he  data  were  analyzed  using  SPSS  19.0  (SPSS,  Inc.,  Chicago,
L,  USA).
esults
atient  characteristics
he  subjects  were  divided  into  2  groups:  a  non-diabetic
roup  (non-DM:  112  vessels,  93  patients)  and  a  diabetic
roup  (DM:  63  vessels,  53  patients).  Baseline  patient  charac-
eristics  are  shown  in  Table  1.  In  the  DM  group,  63.9%  (n  =  40)
f  patients  were  treated  with  oral  hypoglycemic  agents  and
.3%  (n  =  9)  with  insulin.  There  were  no  signiﬁcant  differ-
nces  between  the  2  groups  in  age,  gender,  or  traditional
oronary  risk  factors.
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ngiographic  ﬁndings
oronary  angiographic  ﬁndings  are  summarized  in  Table  2.
here  were  no  signiﬁcant  differences  in  diseased  vessels  and
esion  site.
ray-scale  IVUS  ﬁndings
ray-scale  IVUS  data  are  presented  in  Table  3.  In  the
D  analysis,  there  were  no  signiﬁcant  differences  in  IVUS
arameters  between  the  2  groups.  However,  3D  volumetric
nalysis  revealed  that  the  DM  group  tended  to  have  larger
laque  volumes  and  percent  plaque  burdens.
MAP-IVUS  ﬁndings
t  minimum  lumen  sites,  the  absolute  lipidic  and  necrotic
reas  and  the  percent  lipidic  and  necrotic  areas  were  sig-
iﬁcantly  greater  in  the  DM  than  in  the  non-DM  group;
onversely,  percent  ﬁbrotic  area  was  signiﬁcantly  smaller  in
he  DM  group  (Fig.  2A  and  B).  In  addition,  the  absolute  lipidic
nd  necrotic  volumes  and  the  percent  lipidic  and  necrotic
olumes  were  signiﬁcantly  greater  in  the  DM  than  in  the  non-
M  group,  while  percent  ﬁbrotic  volume  was  signiﬁcantly
maller  in  the  DM  group  (Fig.  3A  and  B).
ntra-  and  inter-observer  variability  of  iMAP-IVUS
nalysis
ntra-observer  variability  yielded  good  concordance  for  EEM
olume,  lumen  volume,  plaque  volume,  and  plaque  com-
onents  by  iMAP-IVUS:  r  =  0.93  for  EEM,  r  =  0.95  for  lumen,
 =  0.94  for  plaque,  r  =  0.88  for  the  ﬁbrotic  component,
 =  0.90  for  the  lipidic  component,  r  =  0.93  for  the  necrotic
omponent,  and  r  =  0.94  for  the  calciﬁed  component.  Inter-
bserver  variability  was  also  acceptable:  r  =  0.90  for  EEM,
 =  0.88  for  lumen,  r  =  0.88  for  plaque,  r  =  0.80  for  the  ﬁbrotic
omponent,  r  =  0.84  for  the  lipidic  component,  r  =  0.82  for
he  necrotic  component,  and  r  =  0.88  for  the  calciﬁed  com-
onent.
iscussion
he  main  ﬁnding  of  the  present  study  is  that  stable  ischemic
eart  disease  is  associated  with  larger  lipidic  and  necrotic
laques  in  target  vessels  in  DM  than  in  non-DM  patients.
revious  studies  demonstrated  DM  to  be  a  leading  cause
f  atherosclerosis  and  that  the  incidence  of  cardiovascu-
ar  mortality  was  higher  than  in  the  general  population
12].  It  has  been  proposed  that  a  large  lipid  and  necrotic
ore  is  the  one  of  the  markers  deﬁning  vulnerable  plaques
rone  to  rupture  and  thrombosis  [13]. One  autopsy  study
f  sudden  coronary  death  patients  found  inﬂammation  and
he  necrotic  core  burden  to  play  a  much  greater  role
n  the  progression  of  atherosclerosis  in  DM  than  in  non-
M  patients  [14]. Furthermore,  previous  ex  vivo  studies
howed  DM  patients  to  have  more  lipid-rich  content  and
acrophage  inﬁltration  of  coronary  atherectomy  specimens
15].  These  results  suggest  that  patients  with  DM  are  at
reater  risk  of  developing  vulnerable  plaque  associated  with
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Figure  1  Plaque  characterization  using  gray-scale  intravascular  ultrasound  (IVUS)  and  iMAP.  (A)  Coronary  angiography  (CAG)
revealed 90%  stenosis  in  the  middle  left  circumﬂex  artery.  (B)  Longitudinal  imaging  of  culprit  lesion  using  iMAP-IVUS.  (C)—(E)  Four
cross-sectional gray-scale  IVUS  (upper  panels)  and  iMAP-IVUS  (lower  panels)  images  from  proximal  (C)  to  distal  (E)  within  a  culprit
lesion. (D)  The  minimum  lumen  site.  iMAP-IVUS  demonstrate  green  for  ﬁbrotic  plaque,  yellow  for  lipidic  plaque,  red  for  necrotic
plaque, and  blue  for  calciﬁed  plaque.  External  elastic  membrane  area,  lumen  area,  and  plaque  area  were  18.61  mm2,  2.87  mm2,
and 15.74  mm2,  respectively,  in  (D).  The  ﬁbrotic,  lipidic,  necrotic,  and  calciﬁed  areas  were  8.47  mm2 (53%),  1.73  mm2 (10%),
4.51 mm2 (28%),  and  0.02  mm2 (0%),  respectively,  in  (D).  External  elastic  membrane  volume,  lumen  volume,  and  plaque  volume  are
3 3 3 rotic 3
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a545.49 mm ,  151.40  mm ,  and  394.10  mm ,  respectively.  The  ﬁb
30.47 mm3 (7%),  106.08  mm3 (26%),  and  9.11  mm3 (2%),  respect
acute  coronary  events.  A  human  study  using  VH-IVUS  demon-
strated  similar  ﬁndings  in  stable  angina  pectoris  patients  [6].
Also,  in  integrated  backscatter  (IB)-IVUS  analyzed  plaque
component  using  IB  value,  lipid  area  and  volume  in  hyperin-
sulinemia  and  lipid  core  in  DM  is  larger  than  non-DM  [16,17].
The  results  of  this  report  appear  to  be  consistent  with  our
data  showing  DM  patients  to  have  large  lipidic  and  necrotic
plaques  at  culprit  lesion  sites.  It  is  noteworthy  that  dif-
ferences  in  plaque  characteristics  were  observed  despite
both  groups  of  patients  having  stable  ischemic  heart  disease.
Furthermore,  previous  studies  demonstrated  culprit  lesions
in  DM  patients  to  be  characterized  by  negative  remodel-
ing,  a  larger  plaque  burden,  and  more  diffuse  disease  [18].
We  detected  no  difference  in  vessel  volume  between  DM
and  non-DM  patients,  though  plaque  volume  tended  to  be
t
g
h
i,  lipidic,  necrotic,  and  calciﬁed  areas  were  231.12  mm (58%),
reater  in  the  DM  group.  These  ﬁndings  suggest  that  adapta-
ion  via  coronary  remodeling  is  minimal  in  diabetic  patients,
n  observation  apparently  consistent  with  those  of  previous
tudies  [19]. DM  patients  have  diffuse  atherosclerosis  and
 large  plaque  burden.  Therefore,  it  seems  reasonable  that
issue  characterization  by  volumetric  analysis  yields  more
nformation  than  a  2D  image.
iMAP-IVUS  not  only  allows  online  delineation  of  tissue
omponents  for  each  category,  but  also  provides  real-
ime  40  MHz  high-resolution  gray-scale  images,  which  are
lso  fundamentally  important.  Most  previous  intra-coronary
issue  classiﬁcation  studies  employed  VH-IVUS,  in  which
ray-scale  resolution  is  only  20  MHz  [6,20—23].  2D  analysis
as  the  same  limitation.  After  the  aforementioned  stud-
es,  VH-IVUS  was  introduced  in  clinical  settings  and  then
46  T.  Araki  et  al.
Table  1  Baseline  characteristics.
Non-DM  (n  =  112)  DM  (n  =  63)  p-Value
Age  (years)  69.6  ±  9.9  68.03  ±  12.4  0.87
Male gender  (%)  94  (83.9)  49  (79.1)  0.41
Smoking (%)  50(44.6)  34  (54.0)  0.30
Prior MI  (%)  14  (12.5)  5  (7.9)  0.50
Prior CABG  (%) 5  (4.5)  1  (1.6)  0.57
Family history  (%) 14 (12.5)  6 (9.5)  0.73
Ejection fraction  (%) 60.81  ±  12.77  59.15  ±  13.71  0.43
Hypertension  (%) 89 (79.5)  56 (88.9)  0.17
Hyperlipidemia  (%)  69  (61.6)  45  (71.4)  0.25
Hemodialysis  (%)  11  (9.8)  8  (12.7)  0.73
eGFR (ml/min/1.73  m2)  45.15  ±  18.29  42.89  ±  26.12  0.50
Fasting blood  glucose  (mg/dl) 107.72  ±  25.01  143.43  ±  47.26  <0.0001
Hemoglobin  A1C  (%)  5.83  ±  0.32  7.01  ±  1.17  <0.0001
Total cholesterol  (mg/dl)  173.52  ±  41.15  170.62  ±  32.59  0.63
Triglyceride  (mg/dl)  134.83  ±  116.04  (71.1—140.9)a 122.35  ±  58.00  (67.5—158.5)a 0.43
LDL-cholesterol  (mg/dl)  97.22  ±  34.07  97.61  ±  28.43  0.94
HDL-cholesterol  (mg/dl)  51.12  ±  14.77  48.27  ±  10.73  0.19
Statin use  (%)  68  (60.7)  43  (68.3)  0.41
ACE-I or  ARB  use  (%) 58  (51.8)  44  (69.8)  0.09
Oral hypoglycemic  agents  (%)  40  (63.9)
Insulin user  (%) 9  (14.3)
Data are presented as the number (%) of patients or means ± SD.
DM, diabetes mellitus; MI, myocardial infarction; CABG, coronary artery bypass grafting; eGFR, estimated glomerular ﬁltration rate; LDL,
low-density lipoprotein; HDL, high-density lipoprotein; ACE-I, angiotensin-converting enzyme inhibitors; ARB, angiotensin II receptor
blocker.
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idely  used,  although  disagreements  persist  regarding  its
ccuracy  [24,25].  In  iMAP-IVUS,  further  prospective  studies
re  required  to  validate  our  ﬁndings  and  conﬁrm  the  useful-
ess  of  this  new  modality,  which  may  provide  more  in  depth
nformation  about  tissues  [26,27].
imitationsirst,  this  was  a  single  center,  retrospective  study.  Selec-
ion  bias  cannot  be  entirely  avoided.  Second,  we  excluded
atients  with  restenosis  after  stent  implantation  and
t
s
c
e
Table  2  Coronary  angiographic  ﬁndings.
Non-DM  (n  =  112)  
Diseased  vessel  (%)  
Left main  4  (3.6)  
Left anterior  descending  46  (41.1)  
Left circumﬂex  22  (19.6)  
Right 40  (35.7)  
Lesion site  (%)  
Proximal 54  (48.2)  
Middle 41  (36.6)  
Distal 17  (15.2)  
Data are presented as the number (%) of patients.
DM, diabetes mellitus.nadequate  IVUS  images.  Therefore,  this  study  might  not
epresent  the  entire  spectrum  of  patients  with  angina
ectoris.  Third,  the  present  iMAP-IVUS  modality  is  unable
o  differentiate  thrombus  from  other  plaque  components.
lthough  we  excluded  angiographically  detected  thrombus,
 small  thrombus  within  plaque  CSA  might  lead  to  incorrect
issue  characterization.  In  a  future  study,  it  will  be  necessary
o  develop  an  iMAP-IVUS  algorithm  for  thrombus.  Fourth,
ome  areas  of  plaque  were  unsuitable  for  analysis  due  to
alciﬁcation  and  guide-wire  artifacts.  Fifth,  while  nitroglyc-
rin  was  administered  before  IVUS  imaging,  the  occurrence
DM  (n  =  63)  p-Value
0.85
4  (6.3)
24  (38.1)
13  (20.6)
22  (34.9)
0.87
28  (44.4)
24  (38.1)
11  (17.5)
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Table  3  Gray-scale  intravascular  ultrasound  ﬁndings.
Non-DM  (n  =  112)  DM  (n  =  63)  p-Value
Gray-scale  IVUS  analysis  (2D)
External  elastic  membrane  area  (mm2)  12.75  ±  4.40  12.59  ±  4.08  0.82
Lumen area  (mm2)  3.11  ±  1.24  2.87  ±  0.89  0.19
Plaque area  (mm2)  9.64  ±  3.77  9.73  ±  3.83  0.88
Plaque burden  (%)  74.72  ±  7.98  75.58  ±  8.89  0.52
Gray-scale IVUS  analysis  (3D)
External  elastic  membrane  volume  (mm3)  193.49 ±  115.08  225.04  ±  148.82  0.12
Lumen volume  (mm3)  55.65 ±  36.88  59.53 ±  37.06  0.51
Plaque volume  (mm3)  136.44 ±  88.53  165.51 ±  120.39  0.07
Plaque burden  (%) 68.4 ±  11.6  71.3 ±  10.5  0.10
Lesion length  (mm)  16.06  ±  7.77  18.04  ±  8.48  0.12
Data are presented as means ± SD.
DM, diabetes mellitus; IVUS, intravascular ultrasound.
Figure  2  Absolute  and  relative  plaque  areas  at  minimum
lumen  sites.  The  absolute  (A)  and  relative  (B)  areas  at  minimum
lumen sites  in  a  subset  of  175  vessels  undergoing  iMAP-
intravascular  ultrasound  (IVUS)  are  shown.  The  absolute  lipidic
and necrotic  areas  and  percent  lipidic  and  necrotic  areas  were
signiﬁcantly  greater  in  the  diabetes  mellitus  (DM)  than  in  the
non-DM  group;  conversely,  the  percent  ﬁbrotic  area  was  signif-
icantly  smaller  in  DM  group.
Figure  3  Volumetric  absolute  and  relative  plaque  com-
ponents.  Volumetric  absolute  (A)  and  relative  (B)  plaque
components  in  a  subset  of  175  vessels  undergoing  iMAP-
intravascular  ultrasound  (IVUS)  are  shown.  The  absolute  lipidic
and necrotic  volumes  and  percent  lipidic  and  necrotic  volumes
were  signiﬁcantly  greater  in  the  diabetes  mellitus  (DM)  than  in
the non-DM  group;  conversely,  the  percent  ﬁbrotic  volume  was
signiﬁcantly  smaller  in  the  DM  group.
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f  vasospasm  cannot  be  completely  ruled  out.  Sixth,  only
essels  undergoing  PCI  were  examined.  Finally,  the  culprit
esions  analyzed  constituted  only  a  small  part  of  the  entire
oronary  arterial  system.
onclusion
MAP-IVUS  revealed  that  DM  patients  have  signiﬁcantly
arger  lipidic  and  necrotic  plaque  volumes  than  non-DM
atients.
onﬂicts of interest
one.
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